Being Bimodal May 28, 2020 The five imperatives of all Quality Leaders Regardless of industry or company size, all Quality leaders share these five key imperatives. Arguably, I place product quality as paramount. In life sciences, more than any other industry, product efficacy is vital; does it do what it was designed to do? These two ensure patient safety, the ultimate accountability of the industry. Next comes continuity of supply of both existing and new product. Finally, compliance. I intentionally, and perhaps provocatively, put compliance last in this list. We know from data that a company can have a good compliance record but that may not necessarily be accompanied by good product quality, while the converse is frequently to be true: a company with good product quality tends to have that accompanied by a strong compliance performance. These five things core accountabilities are connected. The Quality Management System is called a system, not because it is executed in a software platform but because it is designed to be an interconnected, closed loop of processes that inform quality by design. Quality transfers that design into manufacturing, quality of manufacturing and supply all the way to patient. Then, from the patient back to continuous improvement of the initial design and manufacture, and ultimately through the end-of-life of that product. End-to-end quality management Product quality is complexThe quality of medical products is, of course, a complex topic. Simply put, it could be defined as a measure of how well that product meets established specifications and tolerances when tested against them. However, there are so many opportunities for quality events to effect product quality along the complex value chain, especially when we consider that value chain starts with ideation, discovery, design and development – and ends all the way out at the patient. Those specifications and tolerances have to be designed into the product. Quality By Design (QBD), Critical To Quality (CTQ) flow down: design for manufacture, supplier selection, raw material selection. All of these front-end aspects can affect product quality. Then imagine all the touch points on product, just on the factory floor alone: raw material incoming inspection, raw material storage, ordering, picking; manufacturing equipment calibration and performance; environmental controls, human intervention, finishing and packing, testing and release; shipping, distribution, storage, stability, and usage once product leaves the factory. These represent the countless opportunities for quality to be adversely affected. Compliance is still a challengeIt’s interesting that we still see so much priority given to complying with regulation over the other four of these imperatives. For me, compliance is just the ticket to the game. For many firms, compliance is still the number one goal of their quality organization. But if that’s the case, then the regulators have unintentionally created the opposite effect to that they set out to create. Their purpose is, and always has been, to promote and protect public health, not to cause manufactures regulatory nightmares. Talk to any of them today, and they will tell you that is true. I’ve discussed it just recently with several offices of the US FDA, and we were clearly aligned on that thinking. But let’s get real for a moment. The fact is that, while we should place compliance in its appropriate position of priority, it is a daily challenge for even those most mature of companies. Often large firms have some inspection taking place in some facility by some regulator, every single day of the year. Small and mid-size firms still struggle to meet even the basic requirements of increasing challenging and ever-changing regulation, so I don’t want to downplay the importance and significance of the problem. The FDA and other global regulators establish and enforce regulations to assure public health and patient safety. It can be difficult to feel it when you are a medical product manufacturing plant under inspection, there has clearly been a discernable rebalance on the part of most global regulatory agencies, as they became more risk-based in their approach. Bi-modality and the macro industry trends affecting qualityWhile these five things are front and center of the quality professional’s mind every hour of the day, increasingly over the past five years they are faced with a bi-modal challenge.Mode 1 is about operational stability, predictability, efficiency and incremental continuous improvement often characterized by the need to drive down Total Cost of Quality (TCoQ). Mode 1 is risk-averse and focused on prevention. Mode 1 can be seen as these micro challenges effecting quality.Mode 2 is exploratory. It is about innovative, creative out-of-the-box solutions. Mode 2 is about speed and big-step changes. It is risk-tolerant and proactive, where fast failure is allowed. Digital transformation and Industry 4.0 epitomize Mode 2.For Quality, Mode 2 can be characterized by seven macro industry trends: Process complexity and variability Pace of innovation Novel medical product Industry 4.0 Supply Chain Complexity Patient Centricity Total Cost of Quality (TCoQ) Continue to Shaping Proactive Quality About the author Stephen McCarthy is Vice President of Digital Innovation at Sparta Systems, acting as chief industry evangelist and customer advocate for Sparta. Steve has nearly three decades of experience as a quality and supply chain leader within the healthcare industry. Prior to joining Sparta, he held several high-profile positions within Johnson & Johnson, the most recent of which was as VP of Quality Systems Shared Services for their Pharmaceuticals, Medical Devices and Consumer sectors. His earlier career was spent in virology research at the University Hospital St. Thomas’ in London. He is a certified six-sigma process excellence black-belt as well as a certified 3rd degree black-belt karate instructor. Share via: Twitter LinkedIn Facebook Email
EVENT 9th GCC Regulatory Affairs Pharma Summit (and Quality Conference) 2024 GCC Regulatory Affairs Pharma Summit is an annual event that provides platform for pharmaceutical regulatory experts and industry professionals in the GCC region to share insights and discuss about the latest updates in the pharmaceutical regulations. We are Gold Sponsors of the 9th GCC Regulatory Affairs Pharma Summit 2024. Learn more
EVENT Honeywell Life Sciences Innovation Days Honeywell invites you to join us for one of our Life Sciences Innovation Days, a series offered throughout the globe in 2024. We will present a variety of process innovations to support the digital transformation of life sciences manufacturing. Themes will include orchestrating systems and data, preventing and containing cyber incidents, quality control and management, modular automation, and the Honeywell life sciences roadmap. Discussion will address streamlining manufacturing, creating batch records, and fulfilling regulatory reporting requirements. Learn more
EVENT Pharma Manufacturing World Summit Join us at Pharma Manufacturing World Summit on May 14, 2024 where Honeywell's Zillery Fortner will be co-presenting on "The Value of a Unified Life Sciences Solution in Pharma 4.0." Learn more
EVENT TUG Europe Join industry peers at one of these FREE events for TrackWise and TrackWise Digital customers, with two dates and locations to choose from. Enjoy a networking at our pre-event receptions, as we celebrate 30 years of TrackWise! Take advantage of a FREE TrackWise Digital pre-event training workshop. Learn more
EVENT RQA 2024: International QA Conference With diverse industry representation including regulatory authorities like the MHRA, it’s a hotspot for those in GCP, GLP, GMP, pharmacovigilance, and more. The conference has evolved to cover a wider scope, offering unparalleled networking opportunities across three dynamic days for delegates, sponsors, and exhibitors to engage on pivotal industry topics. Register to attend this insightful event where you can hear our Industry Business Development Director, Fabrizio Mangilio deliver one of this year's RQA 2024 keynote sessions. We are Platinum Sponsors of the RQA 2024: International QA Conference Learn more
WEBINAR AI-Driven Innovation: Redefining Quality Management in Life Sciences Take a deep dive into the confluence of AI and life sciences, exploring how artificial intelligence is poised to revolutionize the realm of quality management in the sector. Learn more
EBOOK 5 Things to Know About EUDAMED EUDAMED (European database for medical devices) is a centralized database that aims to enhance the transparency and traceability of medical devices in the EU. Learn more
WEBINAR EUDAMED 2024 and Beyond: Preparing for the Future of Medical Device Oversight Watch our on-demand webinar and gain valuable insights into the transformative impact of EUDAMED on the Medical Device industry. Learn more
WHITE PAPER Future-Proofing a Pharma Manufacturing Legacy through Digital Quality Transformation As industries adopt technological advances and rapidly move into the fourth industrial revolution, it is essential to assess the impact of these isolated data pockets on the workforce, customers and the safety of patients. Learn more
WHITE PAPER Bridging the Gap: Integrating Quality and Document Management When quality and document management systems are integrated, life sciences companies can maximize the value of each platform and create a “total quality” environment. Learn more
WHITE PAPER Harnessing Quality Management Innovation in Life Sciences Discover the Power of Quality, Data, and Patient-Centricity in Life Sciences through Exclusive Whitepapers with CIO.com and Salesforce Learn more
ON-DEMAND TrackWise Digital®: Managing Complaints with AI QualityWise.ai: Auto-Categorization Product Demo Video Learn more